32 research outputs found
(A) clinical study on toxemia of pregnancy
์ํ๊ณผ/์์ฌ[ํ๊ธ]
[์๋ฌธ]
This study was undertaken for clinical evaluation on the women with toxemia of pregnancy who was admitted to Yonsei University Medical Center from April, 1966 to December, 1970.
By evaluating 583 cases of toxemia of pregnancy among total 8253 deliveries, following results were obtained.
1. The incidence of toxemia was 7.06%
2. According to the classification of American Committee on Maternal welfare, the incidence of toxemia were as follows;
Mild pre-eclampsia : 33.9%
Severe pre-eclampsia : 43.8%
Eclampsia : 17.5%
Chronic hypertensive vascular disease with superimposed acute toxemia : 3.9%
Chronic hypertensive vascular disease without acute toxemia : 0.5%
unclassified : 0.4%
3. Age distribution of toxemia was highest among 25-29 years range(42.5%).
4. 48.2% of toxemia was primipara and 51.8% of toxemia was multipara.
5. The numbers of toxemia were most spring time(28.66%), but no definits significance on seasonal variation.
6. The distribution between clinic xases and private cases was higher in clinic cases(71.5%).
7. Among the associated disease with toxemia of pregnancy were 28 cases(4.8%), and abruptio placentae were 23 cases(3.9%). Other diseases were essential hypertension, polyhydramnios and diabetes mellitus.
8. The total numbers of deliveries were increased yearly, but there was no remarkable change on rate of antenatal visit. There was a tendency of decrease on incidence of toxemia of pregnancy yearly.
9. The symptoms of toxemia of pregnancy disappeared on postpartum third day, in order of edema, hypertension, and proteinuria on each toxemic groups.
10. Perinatal mortality rate of toxemia was 121/1,000 live birth and it was very high value contrast to overall perinatal mortality rate(36.4/1,000 live births).restrictio
Morphologic alterations of the uterine cervix of rats induced by estrogen, progesterone and ortho-novum
์ํ๊ณผ/๋ฐ์ฌ[ํ๊ธ]
์ธ๊ณ์ ์ผ๋ก ํฝ์ฐฝ๋๋ ์ธ๊ตฌ์ฆ๊ฐ์ ์กฐ์ ์ด ์ฌ๊ฐํ ๋ฌธ์ ๋ก ๋ถ๊ฐ๋จ์ ๋ฐ๋ผ ์ฌ๋ฌ ๊ฐ์ง ํผ์๋ฐฉ๋ฒ์ด ์ฐ๊ตฌ๋๊ณ ์์ผ๋ฉฐ ์ด์ค ๊ฒฝ๊ตฌํผ์์ฝ์ ๊ฐ์ฅ ์์ ํ๊ณ ํจ์จ์ ์ธ ๋ฐฉ๋ฒ์ผ๋ก์ ๋๋ฆฌ ์ด์ฉ๋๊ณ ์๋ค.
๊ฒฝ๊ตฌํผ์์ ์ ์ฃผ ์์ฉ์ ๋ํ์์ฒด ์ ์ฝ์์ ์ฑ์ ์๊ทนํธ๋ฅธ๋ชฌ์ ๋ถ๋น๋ฅผ ์ต์ ํ์ฌ ๋ฐฐ๋์ ๋ฐฉํดํ๋ ๊ฒ์ด์ง๋ง ๊ทธ ๋ฐ์ ์์๊ด ์ฌ๋ฌ ๋ถ์์๋ ์์ฉํ์ฌ ๋ถ์์ ์ด๋ํ๋ ๊ฒ์ผ๋ก ์๋ ค์ ธ ์๋ค. ํนํ Pincus ๋ฐ Chang(1958), Tyler(1964)๋ฑ์ ํผ์์ ์ ์ํ ํผ์๊ธฐ์ ์ ์ผ๋ถ๋ก์ ์๊ถ๊ฒฌ๊ด ์ ์ก ๋ฌผ์ง์ ๋ฌผ๋ฆฌํํ์ ์ฑ์์ ๋ณํ๋ฅผ ์ฃผ์ฅํ ๋ฐ ์์ผ๋ฉฐ Rudel๋ฑ(1075)๋ ํผ์์ ๋ฅผ ์ด์ฉํ ๊ฒฝ์ฐ ๋์๋ก๋ถํฐ ๋ฐฐ๋์ ๋๋ฉด์ ํผ์์ด ๋๋ ๊ฒ์ ๊ด์ฐฐํ ๋ฐ ์๋ค.
๋ฐฐ๋์ต์ ๋ฅผ ์ํ์ฌ estrogen์ ํฌ์ฌ๋ฐ์ ์ฌ๋์ ๊ฒฝ์ฐ ์ฝ ๋ฐ์์์๋ ์๊ถ๊ฒฝ๊ด์ ์ ์ก๋ด์ ์ ์๊ฐ ์ด์ ์์ง์ด๋ ๊ฒ์ ๊ด์ฐฐํ ์ ์์ผ๋(Jackson, 1961; Jackson, 1963), Guard(1960)์ Martinez-Manautous๋ฑ(1966)์ estrogen๊ณผ progesterone์ ๋ณตํฉํฌ์ฌํ๊ฑฐ๋ ์๋
์ progesterone์ ๊ณ์ ํฌ์ฌํ ๊ฒฝ์ฐ์ ์๊ถ๊ฒฝ๊ด์์ ๋ถ๋น๋๋ ์ ์ก์ ์ ๋๊ฐ ๋์์ ์ ์์ ์
์ด ๋ฐฉํด๋๋ค๊ณ ๋ณด๊ณ ํ์๋ค. ๊ทธ๋ฌ๋ ๊ฒฝ๊ตฌํผ์์ ๊ฐ ์๊ถ๊ฒฝ๊ด์ ๋ฏธ์น๋ ์ํฅ์ ๋ํ ์ฐ๊ตฌ๋ ์ฃผ๋ก ์ ์ก๋ฌผ์ง์ ๋ฌผ๋ฆฌํํ์ ๋ณํ์ ์ด๋ก ์ธํ ์ ์์ ์ ์ก ํฌ๊ณผ์ฑ์ ๋ณํ์ ๋ถ๊ณผํ์์ผ๋ฉฐ(Moghissi, 1966; Carlborg๋ฑ, 1969; Elstein๋ฑ, 1976), ๊ฒฝ๊ด ์ํผ์ธํฌ์ ์ ์ก ๋ถ๋นํํ์์ ๊ด์ฐฐํ ์ฐ๊ตฌ๋ ๋๋ฌผ๋ค.
๋ณธ ์คํ์์๋ estrogen ๋ฐ progesterone์ ๋จ๋
ํฌ์ฌ ๋ฐ ํผํฉ์ ์ธ ๊ฒฝ๊ตฌํผ์์ฝ Ortho-Novum์ ํฌ์ฌํ ํ ๋ฐฑ์ ์๊ถ๊ฒฝ๋ถ ์ํผ์ธํฌ์ ์ ์ก๋ถ๋น ์ํฉ์ ์กฐ์งํํ์ ๋ฐ ์ ์ํ๋ฏธ๊ฒฝ์ ๋ฐฉ๋ฒ์ผ๋ก ๋น๊ต ์ฐ๊ตฌํ์๋ค.
์คํ๋๋ฌผ๋ก๋ ์ฒด์ค 200gm๋ด์ธ์ ์์ฑ ๋ฐฑ์๋ฅผ ์ฌ์ฉํ์์ผ๋ฉฐ ๋ค์๊ณผ ๊ฐ์ด 2๊ตฐ์ผ๋ก ๋๋์ด ์คํํ์๋ค.
์ โ
๊ตฐ: ์ ์๋์กฐ๊ตฐ: ์๋ฆฌ์ ์์ผ์ 0.5cc/day(20๋ง๋ฆฌ)
์ โ
ก๊ตฐ: ์คํ๊ตฐ(90๋ง๋ฆฌ)
a. Estrogen๋จ๋
ํฌ์ฌ๊ตฐ: 0.15mg/kg/day(30๋ง๋ฆฌ)
b. Progesterone๋จ๋
ํฌ์ฌ๊ตฐ: 15mg/kg/day(30๋ง๋ฆฌ)
c. Ortho-Novumํฌ์ฌ๊ตฐ: 1.5mg/kg/day(30๋ง๋ฆฌ)
์ ์๋์กฐ๊ตฐ์ ์ง ๋๋ง๊ฒ์ฌ๋ฅผ ์ํํ์ฌ ์ฑ ์ฃผ๊ธฐ์ ๊ฐ ์๊ธฐ๋ฅผ ํ์ธํ ํ ๊ฐ ์๊ธฐ์ 5๋ง๋ฆฌ์ฉ ๋์ดํ์๋ค. ์ฝ๋ฌผ์ 5์ผ์์ 40์ผ๊น์ง ๋งค์ผ ๋ํด๋ถ ๊ทผ์ก์ฃผ์ฌํ์๊ณ , ํฌ์ฌ์์ํ 5์ผ, 10์ผ, 15์ผ, 20์ผ, 30์ผ ๋ฐ 40์ผ์ ๊ฐ 5๋ง๋ฆฌ์ฉ ๋์ดํ์๋ค. ๋์ด ์ฆ์ ์๊ถ ์ ์ฒด๋ฅผ ์ก์์ ์ผ๋ก ๊ด์ฐฐํ ํ ์๊ถ๊ฒฝ๋ถ๋ฅผ ์๊ถ์ฒด๋ถ ๋ฐ ์ง๊ฒฝ๊ณ๋ถ์๋ฅผ ํฌํจํ์ฌ ์ ์ ํ์ฌ 10% ์ค์ฑ formalin์ ๊ณ ์ ํ๊ณ paraffin์ ํฌ๋งคํ ํ 7ฮผ๋๊ป๋ก ๋ฐ์ ํ์ฌ hematoxylin-eosin, periodic acid-Schiff(PAS) ๋ฐ diastase-PAS, alcian blue์ผ์์ ์ํํ์๋ค. ํฌ์์ ์ํ๋ฏธ๊ฒฝ์
๊ฒ์์ ์ํ์ฌ๋ ์กฐ์ง์ 1mm**3 ํฌ๊ธฐ๋ก ๋ฐ์ ํ ํ 1% OsO^^4 ์ ๊ณ ์ ํ๊ณ uranyl acetate์ lead citrate๋ก ์ผ์ํ์ฌ Hitachi H-500์ ์ํ๋ฏธ๊ฒฝ์ผ๋ก ๊ด์ฐฐํ์๋ค. ์ฃผ์ฌ์ ์ํ๋ฏธ๊ฒฝ์ ๊ฒ์์ ์ํ์ฌ๋ ์๊ถ๊ฒฝ๊ด์ ์ํผ์ธํฌ์ธต์ ๋
ธ์ถ์์ผ 3% glutaraldehype์ 1% OsO^^4 ์
๊ณ ์ ํ ํ critical point drier(Hitachi ICP^^2)๋ก ๊ฑด์กฐ์์ผ gold palladium์ผ๋ก ํ์ธต์ ์
ํ ๋ค์ Hitachi S-450 ์ฃผ์ฌ์ ์ํ๋ฏธ๊ฒฝ์ผ๋ก ๊ด์ฐฐํ์๋ค.
์ฐ๊ตฌ๊ฒฐ๊ณผ๋ ๋ค์๊ณผ ๊ฐ๋ค.
1. ์ก์์๊ฒฌ์ estrogenํฌ์ฌ๋ ์๊ถ๊ฒฝ๋ถ ๋ฐ ์ฒด๋ถ๋ฅผ ์ฆ๋์ํค๊ณ progesteroneํฌ์ฌ๋ ์์ถ์ ์ด๋ํ์์ผ๋ฉฐ Ortho-Novumํฌ์ฌ๋ ๋ค์์ ์์ถ์ ์ผ์ผ์ผฐ๋ค. ์๊ถ ๊ฒฝ๊ด๋ด์ ์ ์ก์ estrogenํฌ์ฌ๊ตฐ์์๋ ์ ๋๊ฐ ๋ฎ๊ณ ํผํํ์์ผ๋ฉฐ progesterone๊ณผ Ortho-Novumํฌ์ฌ๊ตฐ์์๋ ์ ๋๊ฐ ๋๊ณ ํฌ๋ช
ํ์๋ค.
2. Estrogen๋จ๋
ํฌ์ฌ๋ ์๊ถ๊ฒฝ๋ถ์ ๊ทน์ธํฌ๋ฅผ ์ฆ์์ํค๊ณ , ์ด๊ธฐ์๋ ์ ์กํ์ฑ์ ์ผ์ผํค๋ฉฐ ํ๊ธฐ์๋ ๊ฐํํ์์ ์ด๋ํ์๋ค.
3. Progesterone๋จ๋
ํฌ์ฌ๋ ๊ทน์ธํ์ธต์ ์ฌํ ์์ถ๊ณผ ํ์ธต์ ์์ฃผ์ํผ์ธํฌํ๋ฅผ ์ด๋ํ์๊ณ ์ ์กํ์ฑ์ด ์ฃผ๋ก ํ์ฆ ์์ฃผ์ํผ์ธํฌ์์ ์ผ์ด๋ฌ๋ค.
4. Ortho-Novum ํฌ์ฌ๋ ํ์ธต ์ํผ์ธํฌ์ ์์ฃผํ์ ๊ทน์ธํฌ์ธต์ ์ฆ์์ ํจ๊ป ์ด๋ํ์์ผ๋ฉฐ ์ ์ก๋ ํ์ธต ์์ฃผ์ํผ์ธํฌ์ ๊ทน์ธํฌ์ธต์์ ๊ณตํ ๊ด์ฐฐํ ์ ์์๋ค.
5. ์ง ์ํผ์ธํฌ์ ์ ์กํ์ฑ์ progesteroneํฌ์ฌ๊ตฐ๊ณผ Ortho-Novumํฌ์ฌ๊ตฐ์์๋ง ํ์ ํ์์ผ๋ฉฐ estrogenํฌ์ฌ๊ตฐ์์๋ ๊ฐํํ์์ด ํ์ ํ์๋ค.
6. ํน์์ผ์์๊ฒฌ์ ๊ทน์ธํฌ์ธต๊ณผ ์์ฃผ์ํผ์ธํฌ์ ์ด๋๋ ๋ญํฌ๋ ์ค์ฑ ๋ฐ ์ฐ์ฑ ์ ์ก๋ค๋น๋ฅ์ ์์ฑ ๋ฐ ์ถ์ ์ ๊ธฐ์ธํ ๊ฒ์ ์ ์ ์์์ผ๋ฉฐ, ์ผ์์ ๊ฐ๋๋ก ๋ณด์ ์ ์ก์ง์ ๋๋๋ Ortho-Novumํฌ์ฌ๊ตฐ์์ ๊ฐ์ฅ ๋์๊ณ estrogenํฌ์ฌ๊ตฐ์์ ๊ฐ์ฅ ๋ฎ์๋ค.
7. ํฌ์์ ์ํ๋ฏธ๊ฒฝ์ ๊ฒ์ฌ์ ๋ญํฌํ์ฑ์ ์ ์ก์ง ์์ฑ์ ์ํ ๊ฒ์ด์์ผ๋ฉฐ, ์ด๋ฌํ ์ ์ก์ง์ ์ฒ์์๋ multivesicular body๋ dense granuleํํ๋ก ์ถํํ๋ค๊ฐ ์ ์ก์๋ญ์ผ๋ก ์ฑ์๋์๋ค. Estrogenํฌ์ฌ๋ ์ด๊ธฐ์ ์์์ multivesicular body์ dense granule์, proge steroneํฌ์ฌ๋ ํฌ์ฌ๊ธฐ๊ฐ์ ์ฆ๊ฐ์ ๋ฐ๋ผ ๋ค์์ granule๊ณผ ์ฝ๊ฐ์ ์ ์ก์๋ญ์, ๊ทธ๋ฆฌ๊ณ Ortho-Novumํฌ์ฌ๋ ๋ค์์ ์ ์ก์๋ญ์ ํ์ฑํ์๋ค.
Estrogenํฌ์ฌ๊ตฐ์ ์ํผํ๋ฉด์ microvilli๊ฐ ๊ธธ๊ณ ๊ท์น์ ์ด๋ฉฐ ์กฐ๋ฐํ์์ผ๋ progesteroneํฌ์ฌ๊ตฐ์์๋ ์์์ ์งง์ microvilli๊ฐ ๋ถ๊ท์นํ๊ฒ ๊ด์ฐฐ๋์๊ณ , Ortho-Novumํฌ์ฌ๊ตฐ์ microvilli๋ ์ด๊ธฐ์๋ estrogenํฌ์ฌ๊ตฐ๊ณผ, ํ๊ธฐ์๋ progesteroneํฌ์ฌ๊ตฐ๊ณผ ๊ฐ์ ๋ชจ์์ด์๋ค.
8. ์ฃผ์ฌ์ ์ํ๋ฏธ๊ฒฝ์ ์๊ฒฌ์ progesterone ๋ฐ Ortho-Novumํฌ์ฌ๊ตฐ์์๋ ํ์ธต์ํผ์ ์์ฃผ์ธํฌํ๋ฅผ ํ์ธํ ์ ์์์ผ๋ฉฐ ํ๋ฉด์ ์ ์ก์๋ญ์ ๋์ถ์ ๊ด์ฐฐํ ์ ์์๋ค.
์ด์์ ๊ฒฐ๊ณผ๋ฅผ ์ข
ํฉํ๋ฉด estrogen์ ๊ทน์ธํฌ์ธต์ ์ฆ์์ํค๊ณ ํฌ์ฌ์ด๊ธฐ์ ์ ๋๊ฐ ๋ฎ์ ์ ์ก์ ๋ถ๋นํ๋ ์ธํฌ๋ก ๋ณํ์ํค๋ ๋ฐ๋ฉด progesterone์ ํ์ธต ์ํผ์ธํฌ๋ฅผ ์์ฃผ์ธํฌํ ์์ผ ์ ๋๊ฐ ๋์ ์ ์ก๋ถ๋น๋ฅผ ์ด๋ํ๋ฉฐ, estrogen๊ณผ progesterone์ ๋ณตํฉ์ ์ธ Ortho-Novumํฌ์ฌ๊ฐ ์๊ถ๊ฒฝ๋ถ์ ์ ์กํ์ฑ์ ๋ฏธ์น๋ ์ํฅ์ ์ด๊ธฐ์ ๊ทน์ธํฌ์ฆ์๊ณผ ํ๊ธฐ์ ์ ์ก๋ถ๋นํ ๋๋ฌธ์ด๋ผ๊ณ ์๊ฐ๋์๋ค.
[์๋ฌธ]
Population control is a world wide problem, and various contraceptive measures are being sought to meet this problem. It is becoming clear that the oral contraceptives will be a choice of methods among various contraceptive means.
The principal contraceptive action of the steroids is believed to be that of ovulation inhibition by inhibiting the secretion of gonadotropins from the anterior pituitary gland.
However, changes in the cervical mucus have been considered as one of th possible contributors to the action of these drugs(Pincus and Chang, 1958; Tyler, 1964). Ovulation can occur on a random basis with all forms of treatment, but pregnancy
does not ensue, presumably owing to cervical factors or endometrium which is not receptive to implantation(Rudel et al., 1965).
The investigation of the cervical role in contraceptive action has been limited to the observation of the physical characteristics of cervical mucus(Mophissi,1966; Carlborg et al., 1969; Elstein et al., 1976), and the migration in vitro or vivo of spermatozoa subsequent to administration of a particular steroid. In patients receiving estrogen therapy for ovulation inhibition, the presence of live, mobile sperm has been demonstrated in the cervical mucus of about half of the treated individuals(Jackson, 1961; Jackson, 1963). However, the administration of either combined therapy or small doses of progestogens continuously causes inhibition of sperm transport due to production of viscus and "hostile" mucus(Guard, 1960; Martinez-Manautous et al., 1966).
A few studes have been carried out on the morphologic alterations of the uterine cervix in mice to see the histogenesis of epidermidization, but not of the characteristic mucification of the cervical epithelium.
The present investigation is aimed to study the morphologic basis of mucus changes in uterine cervix by histochemical and ultrastructural methods following the administration of oral contraceptive(Ortho-Novum) in comparison with the changes induced by progesterone or estrogen alone.
Female albino rats weighing around 200gm were used for the experiment. They were divided into two groups and treated as followings.
Groupโ
. Normal control: Normal saline 0.5cc/day.(20 animals)
Groupโ
ก. Experimental(90 animals)
a. Estrogen treated: 0.15mg/kg/day(30 animals)
b. Progesterone treated: 15mg/kg/day(30 animals)
c. Ortho-Novum treated: 1.5mg/kg/day(30 animals)
Vaginal smears were performed on all of the twenty animals in the normal control group to see each phase of the estrous cycle and five animals were killed in each phase. Drugs are given by intramuscular injection every day for the period from five to forty days. Five animals from each group were killed at the 5th, 10th, 15th, 20th, 30th and 40th days. Uterine cervix including the margin of endometrium and vagina was dissected and examined especially on the characteristics of the mucin in the uterine cervical canal. The tissue was fixed in 10% neutral formalin
for the light microscopic examination.
Microsections were made from paraffin block and were stained by
hematoxyline-osin, periodic acid-Schiff with and without diastase pre-treatment and alcian blue.
For transmission electron microscopic examination, the tissue was cut in 1mm**3 size and fixed in 1% osmium tetraoxide. Sections were stained with uranyl acetate and lead citrate and examined under Hitachi H-500 electron microscope. Fro scanning
electron microscopic examination, the uterine cervix was opened to expose the epithelial surface and fixed in 3% glutaraldehyde in phosphate buffer(pH 7.4) followed by 1% osmium tetraoxide. The tissue was dried with critical point drier(Hitachi ICP2), coated with gold palladium and examined under Hitachi S-450 scanning electron microscope.
The results are as follows.
1. Estrogen induced hypertrophy of the uterine corpus and cervix, while progesterone and Ortho-Novum induced atrophy. The mucus in the uterine cervical canal was watery and turbid in estrogen treated group, while thick, tenaceous and clear in progesterone and Ortho-Novum treated groups.
2. Estrogen induced hyperplasia of the prickle cell layer of the cervix, and caused mucification at early stage but keratinization at latet stage.
3. Progesterone induced atrophy of the prickle cell layer of the cervix and mucification mainly in the superficial cells which had been columnarized by the drug.
4. Ortho-Novum induced superficial columnarization of the epithelium and hyperplasia of the prickle cell layer simultaneously. Mucification occurred not only in superficial columnar cells, but also in the prickle cell layer.
5. The mucification was prominent in vaginal epitheli7um in progesterone and Ortho-Novum treated groups, while the keratinization was conspicus only in estrogen treated group.
6. Special stains revealed the vacuolizations in superficial columnar cells and prickle cells were due to accumulation of acid and neutral mucopolysaccharides, the concentration of which was strongest in Ortho-Novum treated group, and weakest in estrogen treated group.
7. The transmission electron microscopic studies revealed the vacuolization was due to the accumulation of mucus material, which appeared as multivesicular bodies or dense granules, maturing into mucus droplets. A few multivesticular bodies and
dense granules were observed in short term estrogen treatment, whereas many dense granules with a few mucus droplets, and numerous mucus droplets were produced respectively by the administration of progesterone and Ortho-Novum, especially in
long term treatment. The microvilli on the cell surface were compact, long and regular in estrogen treated group, but by the administration of progesterone they became sparse, short and irregular. In animals of short term treatment of Ortho-Novum they were similar to those of estrogen treated group, but became as to
those of progesterone treated one4 following long term therapy.
8. Scanning electron microscopic study also demonstrated superficial columnarization and mucus droplets on the surface in progesterone and Ortho-Novum treated groups.
In Summary, estrogen induce hyperplasia of prickle cells and produce watery mucus, whereas progesterone induce columnarization of surface epithelial cells from which tenaceous, thick mucus is produced, The effect of the Ortho-Novum, a combined oral contraceptive, on the uterine cervix is throught to be the result of early hyperplasia of the prickle cells and later mucification.restrictio